Murine model of cutaneous infection with gram-positive cocci

Staphylococcus aureus has remained an important cause of nosocomial wound infections, but standardized or reproducible systems for analyzing cutaneous infections caused by S. aureus do not exist. A variety of foreign materials, variable inocula, and skin traumas have been used to promote infection. To minimize these variables and ensure reproducibility, we chose a model using subcutaneous injections of a fixed quantity of dextran microbeads (Cytodex) as the foreign material added to standardized broth suspensions of S. aureus. Suspensions (0.2 ml) injected into an outbred strain of immunocompetent hairless mice generated reproducible, measurable lesions. With S. aureus Smith Diffuse, fluctuant, erythematous lesions with a peak diameter of 15 mm were observed; these lesions yielded purulent material containing gram-positive cocci and neutrophils and yielded growth of S. aureus on culture. Lesion size was proportional to the bacterial inoculum size. Histologic examination of excised lesions revealed typical abscesses. A second strain of S. aureus (SLC3) produced dermonecrosis instead of abscesses at an inoculum size of 10(7) CFU. Control injections with a sterile Cytodex suspension regularly produced nondraining, nonerythematous nodules with maximum diameters of less than or equal to 5 mm. Streptococcus pyogenes produced late-onset necrotic lesions and abscesses. Using a foreign substance, this model generates easily observed and reproducible cutaneous infection with S. aureus and streptococci that can potentially discriminate between inter- and intrastrain differences. Such a model could be used to test the pathogenicity of isogeneic strains of these bacterial species and to evaluate the efficacy of antimicrobial agents.

[1]  O. Kinsman,et al.  Experimental staphylococcal infections in newborn mice: inhibition of weight gain as an index of virulence. , 1980, Journal of medical microbiology.

[2]  B. Bean,et al.  Cephalothin clearance of Staphylococcus aureus from two experimental infection sites in the presence and absence of local phagocytic cells. , 1987, The Journal of antimicrobial chemotherapy.

[3]  M. Murai,et al.  Altered Virulence of a Pleiotropic Staphylococcus aureus Mutant with a Low Producibility of Coagulase and Other Factors in Mice , 1989, Microbiology and immunology.

[4]  J. Iandolo Genetic analysis of extracellular toxins of Staphylococcus aureus. , 1989, Annual review of microbiology.

[5]  D. Bor,et al.  Mediastinitis after cardiovascular surgery. , 1983, Reviews of infectious diseases.

[6]  R. Arbeit,et al.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production , 1991, Infection and immunity.

[7]  C. W. Ford,et al.  Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. , 1989, Journal of medical microbiology.

[8]  C. A. Hopkins,et al.  Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size. , 1987, The Journal of infectious diseases.

[9]  T. Foster,et al.  Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement , 1987, Infection and immunity.

[10]  R. Gaynes,et al.  Major trends in the microbial etiology of nosocomial infection. , 1991, The American journal of medicine.

[11]  J. Musser,et al.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Walder,et al.  The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin. , 1989, The Journal of infectious diseases.

[13]  K. Yoshida,et al.  Colonial morphologies of the Smith diffuse strain of Staphylococcus aureus related to mouse virulence. , 1973, Japanese journal of microbiology.

[14]  R. Rossi,et al.  Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. , 1989, The Journal of antimicrobial chemotherapy.

[15]  D. Kernodle,et al.  Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. , 1990, The Journal of infectious diseases.

[16]  R. Sherertz,et al.  Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice , 1989, Antimicrobial Agents and Chemotherapy.

[17]  D. Morgan,et al.  Cutaneous infection in normal and immunocompromised mice , 1986, Infection and immunity.

[18]  M. Sato,et al.  Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice. , 1986, Chemotherapy.

[19]  F. Kapral,et al.  Characterization of a bactericidal lipid developing within staphylococcal abscesses , 1981, Infection and immunity.

[20]  D. Kasper,et al.  Animal model system for studying virulence of and host response to Bacteroides fragilis. , 1990, Reviews of infectious diseases.

[21]  S. D. Elek,et al.  The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. , 1957, British journal of experimental pathology.

[22]  M. Lindberg,et al.  Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning , 1985, Infection and immunity.

[23]  M. O'Reilly,et al.  Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. , 1986, Microbial pathogenesis.

[24]  M. O'Reilly,et al.  Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland , 1989, Infection and immunity.